bpc-157 dosing protocol human BPC-157 Dosing (Common Protocols) ๐น Oral / Subcutaneous โข 500 mcg daily โข Duration: 6 weeks ๐น Intramuscular / Peritendinous โข 1 mg daily โข Duration: 6 weeks โ ๏ธ Note: Not approved normal dose of bpc 157
Description
If a patient really cannot take oral iron, it should be given intravenously, not as an alternative
.webp)
A dose increase and retest is the right next step
It resists degradation from light exposure, temperature fluctuations, and oxidation
Evidence-based benefits include: Promoting blood vessel formation to deliver nutrients and oxygen Accelerating the healing of tendons, ligaments, and gut lining Reducing inflammation and oxidative damage Supporting growth hormone signalling While human clinical data are limited, BPC-157 has been widely used in regenerative protocols for injury recovery and gastrointestinal support
